Indivior Pharmaceuticals, Inc. (INDV): Depreciation & Amortization
$10.00M
Year ended 2025-12-31
$9.00M
Trailing 12 months to 2026-06-30
-14.5%
3-year compound annual growth
| Period ended | Depreciation & Amortization | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $10.00M | -37.5% | 2026-02-26, From 2025-01-01 |
| 2024-12-31 | $16.00M | +6.7% | 2026-02-26, From 2024-01-01 |
| 2023-12-31 | $15.00M | -6.3% | 2026-02-26, From 2023-01-01 |
| 2022-12-31 | $16.00M | n/a | 2025-03-03, From 2022-01-01 |
Depreciation & Amortization at similar companies
| Company | Year ended | Depreciation & Amortization | Change YoY |
|---|---|---|---|
| Indivior Pharmaceuticals, Inc. (INDV) | 2025-12-31 | $10.00M | -37.5% |
| Prestige Consumer Healthcare Inc. (PBH) | 2026-03-31 | $31.27M | +3.6% |
| Alkermes plc. (ALKS) | 2025-12-31 | $27.16M | -4.8% |
| Phibro Animal Health Corp (PAHC) | 2026-06-30 | $51.51M | +13.0% |
| Madrigal Pharmaceuticals, Inc. (MDGL) | 2025-12-31 | $1.51M | +37.4% |
| PTC Therapeutics, Inc. (PTCT) | 2025-12-31 | $38.81M | -48.7% |
| ANI Pharmaceuticals Inc (ANIP) | 2025-12-31 | $91.42M | +35.0% |
| Arrowhead Pharmaceuticals, Inc. (ARWR) | 2025-09-30 | $22.20M | +31.4% |
| Corcept Therapeutics Inc (CORT) | 2025-12-31 | $1.15M | +44.5% |
Compare INDV, PBH, ALKS, PAHC side by side · Screen every company in Pharmaceutical Preparations ↗